Contraceptive Technology Update – April 1, 2011
April 1, 2011
View Issues
-
STD treatment: Time to get on board with expedited partner therapy
Your next patient is a young woman who was in two months ago for a chlamydia infection. You provided her with a prescription and asked that she have her partner come in for evaluation, testing, and treatment. -
Check approach to DMPA and irregular bleeding
Many women might choose the contraceptive injection depot medroxyprogesterone acetate (DMPA, Depo-Provera) for its ease of use, but they might discontinue the method due to irregular bleeding. -
Pay attention to age in chlamydia screening
What is your practice when it comes to screening women for chlamydia? The Centers for Disease Control and Prevention (CDC) recommends annual chlamydia screening for all sexually active young women age 25 and younger. -
Medication abortions: Upswing reported
Findings from a new national report reflect an increase in the use of early medication abortion. -
HPV vaccination in men — How to boost uptake
While the human papillomavirus (HPV) vaccine has been approved for use in men, how many are open to receiving it? New research indicates men might be more willing to receive vaccination when they learn the vaccine can prevent cancer. -
Diaphragms: Update your clinical knowledge
While it is not in the top tier of contraceptive effectiveness, the diaphragm remains an option as a female-controlled method of birth control. What do you know about this form of family planning?